Next Article in Journal
Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis
Next Article in Special Issue
Development of Folate Receptor−Targeted PET Radiopharmaceuticals for Tumor Imaging—A Bench-to-Bedside Journey
Previous Article in Journal
Insights into the Molecular Mechanisms Behind Intralesional Immunotherapies for Advanced Melanoma
Previous Article in Special Issue
Insight into the Development of PET Radiopharmaceuticals for Oncology
 
 
Review

Article Versions Notes

Cancers 2020, 12(5), 1322; https://doi.org/10.3390/cancers12051322
Action Date Notes Link
article xml file uploaded 22 May 2020 11:53 CEST Original file -
article pdf uploaded. 22 May 2020 11:53 CEST Version of Record https://www.mdpi.com/2072-6694/12/5/1322/pdf-vor
article xml file uploaded 28 May 2020 06:31 CEST Update -
article xml uploaded. 28 May 2020 06:31 CEST Update https://www.mdpi.com/2072-6694/12/5/1322/xml
article pdf uploaded. 28 May 2020 06:31 CEST Updated version of record https://www.mdpi.com/2072-6694/12/5/1322/pdf
article html file updated 28 May 2020 06:33 CEST Original file -
article html file updated 5 June 2020 18:52 CEST Update -
article html file updated 9 October 2020 02:48 CEST Update -
article html file updated 21 July 2022 05:40 CEST Update https://www.mdpi.com/2072-6694/12/5/1322/html
Back to TopTop